Medical Hypotheses
Volume 58, Issue 3 , Pages 249-250 , March 2002

Treatment of chronic fatigue syndrome by dietary supplementation with ω-3 fatty acids – a good idea?

Received 28 November 2000 ,Accepted 16 August 2001.

References 

  1. Dyck D, Allen S, Barron J. Management of chronic fatigue syndrome: case study. AAOHN J. 1996;44:85–92
  2. Goshorn RK. Chronic fatigue syndrome. Semin Neurol. 1998;18:237–242
  3. Fukuda K, Straus S, Hickie I. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann Intern Med. 1994;121:953–959
  4. Rhodes LE, Durham BH, Fraser WD, Friedman PS. Dietary fish oil reduces basal and ultraviolet B-generated PGE2 levels in skin and increases the threshold to provocation of polymorphic light eruption. J Invest Dermatol. 1995;105:532–535
  5. Wessely S, Chalder T, Hirsch S, Wallace P, Wright D. The prevalence and morbidity of chronic fatigue syndrome: a prospective primary care study. Am J Public Health. 1997;87:1449–1455
  6. Forsyth LM, Preuss HG, MacDowell AL, Chiazze LJ, Birkmayer GD, Bellanti JA. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol. 1999;82:185–191
  7. Cannon JG, Angel JB, Abad LW. Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. J Clin Immunol. 1997;17:253–261
  8. Evengard B, Schacterle RS, Komaroff AL. Chronic fatigue syndrome: new insights and old ignorance. J Intern Med. 1999;246:455–469
  9. Buchwald D, Wener MH, Pearlman T, Kith P. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J Rheumatol. 1997;24:372–376
  10. Reynolds J. Lipid Regulation Agents. Martindale: The Extra Pharmacopoedia. 31 Ed. London: Royal Pharmaceutical Society; 2000; p. 1276
  11. Mancuso P, Whelan J, DeMichele SJ, Snider CC, Guszcza JA, Karlstad MD. Dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoid biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats. Crit Care Med. 1997;25:1198–1206
  12. Simopolous AP, Salem N. Purslane: A tress trial source of omega-3 fatty acids. N Engl J Med. 1986;315:833
  13. Shahar E, Folsom AR, Melnick SL. Dietary ω-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. N Engl J Med. 1994;331:228–233
  14. Endres E, Ghorbani R, Kelley V, Georgilis K, Lonneman G. The effect of dietary supplementation with omega-3 PUFA on synthesis of IL-1 and TNF. N Engl J Med. 1989;320:265–271
  15. Spirer Z, Koren L, Finkelstein A, Jurgenson U. Prevention of febrile seizures by dietary supplementation with ω-3 polyunsaturated free fatty acids. Med Hypotheses. 1994;43:43–45

PII: S0306-9877(01)91507-5

doi: 10.1054/mehy.2001.1507

Medical Hypotheses
Volume 58, Issue 3 , Pages 249-250 , March 2002

Article Tools